Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia

Clin Cancer Res. 2024 Feb 16;30(4):919. doi: 10.1158/1078-0432.CCR-24-0178.NO ABSTRACTPMID:38362728 | DOI:10.1158/1078-0432.CCR-24-0178

Source: Clinical Cancer Research - February 16, 2024 Category: Cancer & Oncology Authors: Aldo M Roccaro Antonio Sacco Xiaojing Jia Ranjit Banwait Patricia Maiso Feda Azab Ludmila Flores Salomon Manier Abdel Kareem Azab Irene M Ghobrial Source Type: research